Statins and Musculoskeletal Adverse Events

被引:1
|
作者
Finkelstein, Murray M. [1 ]
机构
[1] Univ Toronto, Dept Family & Community Med, Toronto, ON M5T 3L9, Canada
关键词
COHORT; RISK;
D O I
10.1001/jamainternmed.2013.12697
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:302 / 302
页数:1
相关论文
共 50 条
  • [31] Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events
    Tecson, Kristen M.
    Kluger, Aaron Y.
    Cassidy-Bushrow, Andrea E.
    Liu, Bin
    Coleman, Chad M.
    Jones, Laney K.
    Jefferson, Celeena R.
    VanWormer, Jeffrey J.
    McCullough, Peter A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 176 : 37 - 42
  • [32] REPLY: High-Dose Statins Increase Adverse Events and Do Not Improve Survival
    Nelson, Adam J.
    Pagidipati, Neha J.
    Granger, Christopher B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (16)
  • [33] Statins for secondary prevention and major adverse events after coronary artery bypass grafting
    Pan, Emily
    Nielsen, Susanne J.
    Mennander, Ari
    Bjorklund, Erik
    Martinsson, Andreas
    Lindgren, Martin
    Hansson, Emma C.
    Pivodic, Aldina
    Jeppsson, Anders
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (06): : 1875 - 1885
  • [34] A Prospective Stratified Case-Cohort Study on Statins and Multiple Adverse Events in Japan
    Ooba, Nobuhiro
    Sato, Tsugumichi
    Wakana, Akira
    Orii, Takao
    Kitamura, Masaki
    Kokan, Akira
    Kurata, Hideaki
    Shimodozono, Yoshihiro
    Matsui, Kenichi
    Yoshida, Hiroshi
    Yamaguchi, Takuhiro
    Kageyama, Shigeru
    Kubota, Kiyoshi
    PLOS ONE, 2014, 9 (05):
  • [35] STATINS REDUCE MAJOR ADVERSE LIMB EVENTS AND MORTALITY IN PATIENTS WITH PERIPHERAL ARTERY DISEASE
    Pastori, D.
    Farcomeni, A.
    Milanese, A.
    Del Sole, F.
    Menichelli, D.
    Hiatt, W. R.
    Violi, F.
    ATHEROSCLEROSIS, 2020, 315 : E53 - E53
  • [36] Statins and Musculoskeletal Conditions, Arthropathies, and Injuries
    Mansi, Ishak
    Frei, Christopher R.
    Pugh, Mary Jo
    Makris, Una
    Mortensen, Eric M.
    JAMA INTERNAL MEDICINE, 2013, 173 (14) : 1318 - 1326
  • [37] Cardiac adverse events associated with statins in myocardial infarction patients: a pharmacovigilance analysis of the FDA Adverse Event Reporting System
    Deng, Chuanhuan
    Lin, Xiaofang
    Ni, Dan
    Yuan, Ludong
    Li, Jing
    Liu, Yuxuan
    Liang, Pengfei
    Jiang, Bimei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, 47 (01) : 46 - 52
  • [40] Statins and cerebrovascular events
    Auer, J
    Berent, R
    Eber, B
    HERZ, 2002, 27 (08) : 765 - 771